Amedisys, Inc. (AMED)
NASDAQ: AMED · IEX Real-Time Price · USD
92.43
0.00 (0.00%)
At close: May 3, 2024, 4:00 PM
91.53
-0.90 (-0.97%)
After-hours: May 3, 2024, 7:26 PM EDT
Amedisys Revenue
Amedisys had revenue of $2.25B in the twelve months ending March 31, 2024, with 0.76% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $571.41M with 2.70% year-over-year growth. In the year 2023, Amedisys had annual revenue of $2.24B with 0.59% growth.
Revenue (ttm)
$2.25B
Revenue Growth
+0.76%
P/S Ratio
1.34
Revenue / Employee
$118,495
Employees
19,000
Market Cap
3.01B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.24B | 13.18M | 0.59% |
Dec 31, 2022 | 2.22B | 9.09M | 0.41% |
Dec 31, 2021 | 2.21B | 142.59M | 6.88% |
Dec 31, 2020 | 2.07B | 115.89M | 5.93% |
Dec 31, 2019 | 1.96B | 293.06M | 17.63% |
Dec 31, 2018 | 1.66B | 151.31M | 10.01% |
Dec 31, 2017 | 1.51B | 92.01M | 6.48% |
Dec 31, 2016 | 1.42B | 138.72M | 10.83% |
Dec 31, 2015 | 1.28B | 75.99M | 6.31% |
Dec 31, 2014 | 1.20B | -44.79M | -3.59% |
Dec 31, 2013 | 1.25B | -191.49M | -13.29% |
Dec 31, 2012 | 1.44B | 22.37M | 1.58% |
Dec 31, 2011 | 1.42B | -182.61M | -11.41% |
Dec 31, 2010 | 1.60B | 116.69M | 7.86% |
Dec 31, 2009 | 1.48B | 296.96M | 25.01% |
Dec 31, 2008 | 1.19B | 489.48M | 70.13% |
Dec 31, 2007 | 697.93M | 156.79M | 28.97% |
Dec 31, 2006 | 541.15M | 159.59M | 41.83% |
Dec 31, 2005 | 381.56M | 154.47M | 68.02% |
Dec 31, 2004 | 227.09M | 84.62M | 59.39% |
Dec 31, 2003 | 142.47M | 13.05M | 10.08% |
Dec 31, 2002 | 129.42M | 19.25M | 17.47% |
Dec 31, 2001 | 110.17M | 22.02M | 24.98% |
Dec 31, 2000 | 88.16M | -9.26M | -9.50% |
Dec 31, 1999 | 97.41M | 71.95M | 282.51% |
Dec 31, 1998 | 25.47M | -344.00K | -1.33% |
Dec 31, 1997 | 25.81M | -7.71M | -23.01% |
Dec 31, 1996 | 33.52M | -4.07M | -10.82% |
Dec 31, 1995 | 37.59M | 8.69M | 30.06% |
Dec 31, 1994 | 28.90M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Bausch Health Companies | 8.97B |
Progyny | 1.09B |
Sotera Health Company | 1.08B |
Azenta | 641.02M |
10x Genomics | 625.45M |
Amicus Therapeutics | 399.36M |
Immunocore Holdings | 249.43M |
Arrowhead Pharmaceuticals | 181.74M |
AMED News
- 9 days ago - Amedisys Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 6 weeks ago - Oregon's health authority reviewing UnitedHealth's acquisition of Amedisys - Reuters
- 2 months ago - Amedisys Reports Fourth Quarter and Year-End 2023 Financial Results - GlobeNewsWire
- 3 months ago - Amedisys Offers Molecular Testing for Rapid and Accurate Infection Diagnosis - GlobeNewsWire
- 6 months ago - Amedisys Reports Third Quarter 2023 Financial Results - GlobeNewsWire
- 7 months ago - Amedisys Celebrates National Quality Week - GlobeNewsWire
- 8 months ago - Amedisys Recognizes Suicide Prevention Awareness Month and Promotes the 988 Suicide & Crisis Lifeline - GlobeNewsWire
- 10 months ago - Amedisys Reports Second Quarter 2023 Financial Results - GlobeNewsWire